Anti-inflammatory effects of willow bark extract [2]

Clinical Pharmacology and Therapeutics

Volumn 74, Issue 1, 2003, Pages 96-

  Fiebich, Bernd L ^a   Appel, Kurt ^b   Wagner, Irmela ^c   Heide, Lutz ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b VIVACELL BIOTECHNOLOGY GMBH   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DRUG METABOLITE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PLANT EXTRACT; PROSTAGLANDIN E2; SALICIN; SALICYLIC ACID; SALIX EXTRACT; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; BARK; BLOOD SAMPLING; CORRELATION ANALYSIS; CYTOKINE RELEASE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG UTILIZATION; HUMAN; IN VITRO STUDY; LETTER; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; SINGLE DRUG DOSE; WILLOW;

EID: 0038772348     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(03)00116-4     Document Type: Letter

References (0)